Literature DB >> 2078198

Zinc induces specific association of PKC with membrane cytoskeleton.

I J Forbes1, P D Zalewski, C Giannakis, W H Betts.   

Abstract

Putative binding sites for zinc are present in the regulatory domain of protein kinase C but a distinct role for zinc has not yet been proposed. Here we show that micromolar concentrations of zinc chloride cause pure rat brain protein kinase C to localize in a detergent-insoluble, cytoskeletal fraction of red cell membranes and to bind to isolated cytoskeleton in the presence of phosphatidylserine. Attachment of protein kinase C to cytoskeleton was accompanied by enhanced expression of binding sites for 3H-phorbol ester, a regulatory ligand of protein kinase C. The active factor in the cytoskeleton was labile to protease suggesting that protein kinase C binds to a cytoskeletal protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078198

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  6 in total

1.  Subcellular distribution of protein kinase C (pKC) in erythrocytes and concentration of D-myo-inositol-1,4,5-trisphosphate (IP3) in platelets and monocytes of force-fed zinc-deficient rats.

Authors:  H P Roth; C Moser; M Kirchgessner
Journal:  Biol Trace Elem Res       Date:  1996       Impact factor: 3.738

2.  Activity and subcellular distribution of protein kinase C (PKC) in muscle and brain of force-fed zinc-deficient rats.

Authors:  M Kirchgessner; C Moser; H P Roth
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

3.  Phorbol ester-induced actin cytoskeletal reorganization requires a heavy metal ion.

Authors:  K K Hedberg; G B Birrell; O H Griffith
Journal:  Cell Regul       Date:  1991-12

4.  Phosphorylation of membrane proteins in erythrocytes treated with lead.

Authors:  L Belloni-Olivi; M Annadata; G W Goldstein; J P Bressler
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

5.  Effect of pharmacologic doses of zinc on the therapeutic index of brain tumor chemotherapy with carmustine.

Authors:  N Roosen; F Doz; K L Yeomans; D V Dougherty; M L Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction.

Authors:  Keigo Nishida; Aiko Hasegawa; Susumu Nakae; Keisuke Oboki; Hirohisa Saito; Satoru Yamasaki; Toshio Hirano
Journal:  J Exp Med       Date:  2009-05-18       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.